Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications

AbstractPhysicochemical and biopharmaceutical properties of drug substances and dosage forms can be highly affected by the particle size, a critical process parameter in pharmaceutical production. The fundamental issue with particle size analysis is the variety of equivalent particle diameters generated by different methods, which is largely ascribable to the particle shape and particle dispersion mechanism involved. Thus, to enable selection of the most appropriate or optimal sizing technique, cross-correlation between different techniques may be required. This review offers an in-depth discussion on particle size analysis pertaining to specific pharmaceutical applications and regulatory aspects, fundamental principles and terminology, instrumentation types, data presentation and interpretation, in-line and process analytical technology. For illustration purposes, special consideration is given to the analysis of aerosols using time-of-flight and cascade impactor measurements, which is supported by a computational analysis conducted for this review.

[1]  T. Allen Particle Size Measurement , 1965, Nature.

[2]  Recent Developments and Prospects , 1978 .

[3]  Paul A. Baron,et al.  Calibration and Use of the Aerodynamic Particle Sizer (APS 3300) , 1986 .

[4]  John E. Brockmann,et al.  APS Response to Nonspherical Particles and Experimental Determination of Dynamic Shape Factor , 1990 .

[5]  W. D. Griffiths,et al.  The behaviour of regular-shaped non-spherical particles in a TSI aerodynamic particle sizer , 1991 .

[6]  A. Rolland Particulate carriers in dermal and transdermal drug delivery: myth or reality? , 1993 .

[7]  Y. Cheng,et al.  Calibration and performance of an API Aerosizer , 1993 .

[8]  Gary H. Ganser,et al.  A rational approach to drag prediction of spherical and nonspherical particles , 1993 .

[9]  C. Laguerie,et al.  Response of Laser Diffraction Particle Sizer to Anisometric Particles , 1994 .

[10]  H. Yuasa,et al.  Studies on the Granulation Process of Granules for Tableting with a High Speed Mixer. II. Influence of Particle Size of Active Substance on Granulation , 1995 .

[11]  H. Chan,et al.  Physicochemical characterization of a new respirable form of nedocromil. , 1995, Journal of pharmaceutical sciences.

[12]  R. Niven,et al.  The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation , 1996 .

[13]  T. Nagai,et al.  Optimization of Size Distribution of Granules for Tablet Compression , 1996 .

[14]  K. Englmeier,et al.  Aerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavities , 1996 .

[15]  Effect of drug particle size on the release behaviour of NaCl-matrix systems , 1996 .

[16]  Dissolution rate studies of pharmaceutical multisized powders — A practical approach using the coulter method , 1996 .

[17]  N Lotan,et al.  Large porous particles for pulmonary drug delivery. , 1997, Science.

[18]  B. H. Kaye,et al.  The Effect of Shape on Intermethod Correlation of Techniques for Characterizing the Size Distribution of Powder. Part 1: Correlating the Size Distribution Measured by Sieving, Image Analysis, and Diffractometer Methods , 1997 .

[19]  Terence Allen,et al.  Powder sampling and particle size measurement , 1997 .

[20]  Shulin Ding RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .

[21]  R. Langer,et al.  Recent advances in pulmonary drug delivery using large, porous inhaled particles. , 1998, Journal of applied physiology.

[22]  M. Yoshida,et al.  Tableting of Coated Particles. II. Influence of Particle Size of Pharmaceutical Additives on Protection of Coating Membrane from Mechanical Damage during Compression Process. , 1998 .

[23]  R. Haskell Characterization of submicron systems via optical methods. , 1998, Journal of pharmaceutical sciences.

[24]  J. Juraszek,et al.  Structural and magnetic transformations of annealed Tb/Fe multilayers , 1998 .

[25]  S. Rozouvan,et al.  Raman correlation spectroscopy: A method for studying chemical composition and dynamics of disperse systems , 1998 .

[26]  Structural phenomena in hydrogel-drug systems , 1999 .

[27]  N. K. Sinha,et al.  Drag on non-spherical particles: an evaluation of available methods , 1999 .

[28]  F. Podczeck The Influence of Particle Size Distribution and Surface Roughness of Carrier Particles on the in vitro Properties of Dry Powder Inhalations , 1999 .

[29]  G. Rowley,et al.  Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles. , 1999, Drug development and industrial pharmacy.

[30]  B. H. Kaye,et al.  The Effect of Shape on Intermethod Correlation of Techniques for Characterizing the Size Distribution of Powder. Part 2: Correlating the Size Distribution as Measured by Diffractometer Methods, TSI-Amherst Aerosol Spectrometer, and Coulter Counter , 1999 .

[31]  N. Chigier,et al.  OPTICAL MEASUREMENT OF NEBULIZER SPRAYS: A QUANTITATIVE COMPARISON OF DIFFRACTION, PHASE DOPPLER INTERFEROMETRY, AND TIME OF FLIGHT TECHNIQUES , 2000 .

[32]  D. Culler,et al.  Comparison of methods , 2000 .

[33]  J. Dressman,et al.  In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  R. Neuman,et al.  Direct adhesion measurements of pharmaceutical particles to gelatin capsule surfaces , 2000 .

[35]  N A Peppas,et al.  Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. , 2000, International journal of pharmaceutics.

[36]  M. J. Clarke,et al.  The formulation of powder inhalation systems containing a high mass of nedocromil sodium trihydrate. , 2001, Journal of pharmaceutical sciences.

[37]  V. Préat,et al.  Comparison of particle sizing techniques in the case of inhalation dry powders. , 2001, Journal of pharmaceutical sciences.

[38]  D. Grant,et al.  Influence of crystal shape on the tableting performance of L-lysine monohydrochloride dihydrate. , 2001, Journal of pharmaceutical sciences.

[39]  Vidya Swaminathan,et al.  Polydisperse Powder Mixtures: Effect of Particle Size and Shape on Mixture Stability , 2002, Drug development and industrial pharmacy.

[40]  T. Vandamme,et al.  Pulmonary drug delivery systems: recent developments and prospects. , 2002, Critical reviews in therapeutic drug carrier systems.

[41]  Parisa A. Bahri,et al.  Estimating Average Particle Size by Focused Beam Reflectance Measurement (FBRM) , 2002 .

[42]  C. Strumiłło,et al.  DRYING KINETICS AND PARTICLE RESIDENCE TIME IN SPRAY DRYING , 2002 .

[43]  Richard J Martin Therapeutic significance of distal airway inflammation in asthma. , 2002, The Journal of allergy and clinical immunology.

[44]  John D Sherwood,et al.  A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization. , 2002, Journal of pharmaceutical sciences.

[45]  B. Shekunov,et al.  Physical Properties of Supercritically-Processed and Micronised Powders for Respiratory Drug Delivery , 2002 .

[46]  M. Aulton Pharmaceutics : the science of dosage form design , 2002 .

[47]  L. Nagao,et al.  Recommendations to the Food and Drug Administration: Metered Dose Inhaler Tests and Methods in the Chemistry, Manufacturing, and Controls Draft Guidances for Metered Dose Inhalers and Dry Powder Inhalers , 2002 .

[48]  In Situ Measurement of Particle Size during the Crystallization of l-Glutamic Acid under Two Polymorphic Forms: Influence of Crystal Habit on Ultrasonic Attenuation Measurements , 2002 .

[49]  D. F. Steele,et al.  Characterization of a surface modified dry powder inhalation carrier prepared by “particle smoothing” , 2002, The Journal of pharmacy and pharmacology.

[50]  M. L. González-Rodríguez,et al.  In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[51]  B. Shekunov,et al.  Aerosolisation behaviour of micronised and supercritically-processed powders , 2003 .

[52]  Michael G Somekh,et al.  Amplitude and phase microscopy for sizing of spherical particles. , 2003, Applied optics.

[53]  J. Varshosaz,et al.  Nasal delivery of insulin using chitosan microspheres , 2004, Journal of microencapsulation.

[54]  Stephen P. Newman,et al.  Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere® Powder , 2002, Pharmaceutical Research.

[55]  Jeffry D. Schroeter,et al.  Fundamental Effects of Particle Morphology on Lung Delivery: Predictions of Stokes' Law and the Particular Relevance to Dry Powder Inhaler Formulation and Development , 2002, Pharmaceutical Research.

[56]  S. Horkovics-Kovats Characterization of an Active Pharmaceutical Ingredient by Its Dissolution Properties: Amoxicillin Trihydrate as a Model Drug , 2004, Chemotherapy.

[57]  A. Zimmer,et al.  Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[58]  Si-Shen Feng,et al.  Nanoparticles of biodegradable polymers for new-concept chemotherapy , 2004, Expert review of medical devices.

[59]  Production of Powders for Respiratory Drug Delivery , 2004 .

[60]  I. Chang,et al.  Transdermal delivery of mixnoxidil with block copolymer nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[61]  B. Shekunov,et al.  Supercritical fluid technology for drug product development , 2004 .

[62]  Lawrence X. Yu,et al.  Applications of process analytical technology to crystallization processes. , 2004, Advanced drug delivery reviews.

[63]  P. Stewart,et al.  Particle Interactions Involved in Aerosol Dispersion of Ternary Interactive Mixtures , 2002, Pharmaceutical Research.

[64]  U. Kompella,et al.  Pulmonary Delivery of Deslorelin: Large-Porous PLGA Particles and HPβCD Complexes , 2004, Pharmaceutical Research.

[65]  P. Lucas,et al.  Protein Deposition from Dry Powder Inhalers: Fine Particle Multiplets as Performance Modifiers , 1998, Pharmaceutical Research.

[66]  R H Guy,et al.  Skin penetration and distribution of polymeric nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[67]  F. Goli,et al.  Tableting of Eudragit RS and Propranolol Hydrochloride Solid Dispersion: Effect of Particle Size, Compaction Force, and Plasticizer Addition on Drug Release , 2004, Drug development and industrial pharmacy.

[68]  Antonio M. Rabasco,et al.  Relationship Between Drug Percolation Threshold and Particle Size in Matrix Tablets , 1996, Pharmaceutical Research.

[69]  David E. Bugay,et al.  Physical Characterization of Pharmaceutical Solids , 1995, Pharmaceutical Research.

[70]  K. Johnston,et al.  Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs , 2004, Drug development and industrial pharmacy.

[71]  A. Vila,et al.  Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[72]  B. Shekunov,et al.  Thermal Analysis of Trace Levels of Polymorphic Impurity in Salmeterol Xinafoate Samples , 2003, Pharmaceutical Research.

[73]  Barrett E. Rabinow,et al.  Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.

[74]  I. Larson,et al.  Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures. , 2004, Journal of pharmaceutical sciences.

[75]  R. W. Wood,et al.  Nebulization of NanoCrystals™: Production of a Respirable Solid-in-Liquid-in-Air Colloidal Dispersion , 2004, Pharmaceutical Research.

[76]  Michael Hindle,et al.  Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and Next Generation pharmaceutical impactors and their USP methods. , 2004, Journal of pharmaceutical sciences.

[77]  Jerzy Bałdyga,et al.  Fluid Dynamics, Mass Transfer, and Particle Formation in Supercritical Fluids , 2004 .

[78]  A. Bernkop‐Schnürch,et al.  Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[79]  Theerayuth Kaewamatawong,et al.  Acute Pulmonary Toxicity Caused by Exposure to Colloidal Silica: Particle Size Dependent Pathological Changes in Mice , 2005, Toxicologic pathology.

[80]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  Nanoparticle technology for drug delivery: from nanoparticles to cutting-edge delivery strategies - part I. , 2005, IDrugs : the investigational drugs journal.

[82]  Daryl L Roberts,et al.  Relationship of stage mensuration data to the performance of new and used cascade impactors. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[83]  Barrett Rabinow Pharmacokinetics of drugs administered in nanosuspension. , 2005, Discovery medicine.

[84]  M. Goldenberg,et al.  Micrometer-Scale Particle Sizing by Laser Diffraction: Critical Impact of the Imaginary Component of Refractive Index , 2005, Pharmaceutical Research.

[85]  O. Usmani,et al.  Regional Lung Deposition and Bronchodilator Response as a Function of β2-Agonist Particle Size , 2005 .

[86]  Joachim List,et al.  Direct Imaging of Very Fast Particles Opens the Application of the Powerful (Dry) Dispersion for Size and Shape Characterization , 2005 .

[87]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[88]  Pratibhash Chattopadhyay,et al.  Nanoparticles of Poorly Water-Soluble Drugs Prepared by Supercritical Fluid Extraction of Emulsions , 2006, Pharmaceutical Research.

[89]  B. Shekunov Nanoparticle technology for drug delivery: from nanoparticles to cutting-edge delivery strategies - part II. , 2005, IDrugs : the investigational drugs journal.

[90]  N. Chew,et al.  Effect of amino acids on the dispersion of disodium cromoglycate powders. , 2005, Journal of pharmaceutical sciences.

[91]  Isidoro Caraballo,et al.  Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. , 2006, International journal of pharmaceutics.

[92]  W. Kreyling,et al.  Ultrafine particle-lung interactions: does size matter? , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[93]  Lai Wah Chan,et al.  Evaluation of sodium alginate as drug release modifier in matrix tablets. , 2006, International journal of pharmaceutics.

[94]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[95]  Jolyon P. Mitchell,et al.  Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: Comparison of andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer , 2003, AAPS PharmSciTech.

[96]  Shrenik P. Shah,et al.  Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance , 2004, AAPS PharmSciTech.

[97]  Vincent J. Sullivan,et al.  Formulation of a dry powder influenza vaccine for nasal delivery , 2006, AAPS PharmSciTech.

[98]  K Ann McKibbon,et al.  Current status and future prospects. , 2008, Health information and libraries journal.

[99]  A. Hussain,et al.  Assuring quality and performance of sustained and controlled release parenterals: Workshop report , 2008, AAPS PharmSci.

[100]  J. Zimmerman Exposure-response relationships and drug interactions of sirolimus , 2004, The AAPS Journal.

[101]  Anthony J. Hickey,et al.  Particle size analysis: AAPS workshop report, cosponsored by the Food and Drug Administration and the United States Pharmacopeia , 2004, The AAPS Journal.